Filed: 5/13/2026ACC: 0001104659-26-060145
📋 What this filing means
DECHENG CAPITAL LLC filed this quarterly 13F‑HR report disclosing 14 equity positions with a total reported market value of $661.32M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
14
Positions
$661.32M
Total AUM (reported)
54.50M
Total Shares
Allocation by class
COM$655.08M99.1%
SHS$6.23M0.9%
Portfolio Concentration
Top 3$567.10M85.8%
4–10$82.52M12.5%
11–25$11.69M1.8%
Top 3 weight
85.8%
Top 10 weight
98.2%
Voting Authority Distribution
Total shares with voting rights: 54.50M
Sole
Full voting authority
54.50M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole14
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings14
Rows:
CG ONCOLOGY INC
SOLEShares6.37M
TypeSH
Market value$431.23M
65.21%
Sole
6.37M
Shared
0.00
None
0.00
Nuvation Bio Inc.
SOLEShares25.95M
TypeSH
Market value$111.34M
16.84%
Sole
25.95M
Shared
0.00
None
0.00
Upstream Bio Inc.
SOLEShares2.72M
TypeSH
Market value$24.52M
3.71%
Sole
2.72M
Shared
0.00
None
0.00
Aclaris Therapeutics, Inc.
SOLEShares4.04M
TypeSH
Market value$15.16M
2.29%
Sole
4.04M
Shared
0.00
None
0.00
AARDVARK THERAPEUTICS INC
SOLEShares3.92M
TypeSH
Market value$14.77M
2.23%
Sole
3.92M
Shared
0.00
None
0.00
Lyell Immunopharma, Inc.
SOLEShares692.05K
TypeSH
Market value$13.88M
2.10%
Sole
692.05K
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA CO NV
SOLEShares325.06K
TypeSH
Market value$10.41M
1.57%
Sole
325.06K
Shared
0.00
None
0.00
Arcus Biosciences, Inc
SOLEShares477.82K
TypeSH
Market value$10.32M
1.56%
Sole
477.82K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC(NSM)
SOLEShares93.50K
TypeSH
Market value$9.09M
1.37%
Sole
93.50K
Shared
0.00
None
0.00
Equillium Inc.
SOLEShares4.45M
TypeSH
Market value$8.89M
1.34%
Sole
4.45M
Shared
0.00
None
0.00
BeyondSpring Inc.
SOLEShares3.80M
TypeSH
Market value$6.23M
0.94%
Sole
3.80M
Shared
0.00
None
0.00
Zentalis Pharmaceuticals Inc.
SOLEShares1.32M
TypeSH
Market value$3.10M
0.47%
Sole
1.32M
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares7.30K
TypeSH
Market value$1.89M
0.29%
Sole
7.30K
Shared
0.00
None
0.00
Pyxis Oncology, Inc (formerly Apexigen)
SOLEShares326.81K
TypeSH
Market value$477.1K
0.07%
Sole
326.81K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COM | 6.37M | SH | $431.23M 65.21% | 6.37M | 0.00 | 0.00 |
Nuvation Bio Inc.SOLE | COM | 25.95M | SH | $111.34M 16.84% | 25.95M | 0.00 | 0.00 |
Upstream Bio Inc.SOLE | COM | 2.72M | SH | $24.52M 3.71% | 2.72M | 0.00 | 0.00 |
Aclaris Therapeutics, Inc.SOLE | COM | 4.04M | SH | $15.16M 2.29% | 4.04M | 0.00 | 0.00 |
AARDVARK THERAPEUTICS INCSOLE | COM | 3.92M | SH | $14.77M 2.23% | 3.92M | 0.00 | 0.00 |
Lyell Immunopharma, Inc.SOLE | COM | 692.05K | SH | $13.88M 2.10% | 692.05K | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA CO NVSOLE | COM | 325.06K | SH | $10.41M 1.57% | 325.06K | 0.00 | 0.00 |
Arcus Biosciences, IncSOLE | COM | 477.82K | SH | $10.32M 1.56% | 477.82K | 0.00 | 0.00 |
REVOLUTION MEDICINES INC(NSM)SOLE | COM | 93.50K | SH | $9.09M 1.37% | 93.50K | 0.00 | 0.00 |
Equillium Inc.SOLE | COM | 4.45M | SH | $8.89M 1.34% | 4.45M | 0.00 | 0.00 |
BeyondSpring Inc.SOLE | SHS | 3.80M | SH | $6.23M 0.94% | 3.80M | 0.00 | 0.00 |
Zentalis Pharmaceuticals Inc.SOLE | COM | 1.32M | SH | $3.10M 0.47% | 1.32M | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 7.30K | SH | $1.89M 0.29% | 7.30K | 0.00 | 0.00 |
Pyxis Oncology, Inc (formerly Apexigen)SOLE | COM | 326.81K | SH | $477.1K 0.07% | 326.81K | 0.00 | 0.00 |